MARK WARD to Cost-Benefit Analysis
This is a "connection" page, showing publications MARK WARD has written about Cost-Benefit Analysis.
Connection Strength
0.048
-
A cost-effectiveness analysis of bacterial endocarditis prophylaxis for febrile children who have cardiac lesions and undergo urinary catheterization in the emergency department. Pediatrics. 2004 May; 113(5):1291-6.
Score: 0.048